AAPL   318.88 (+0.20%)
MSFT   181.97 (+0.31%)
FB   224.87 (-0.26%)
CGC   17.59 (-18.57%)
BABA   199.13 (-0.47%)
GE   6.54 (-3.68%)
TSLA   821.23 (+1.91%)
T   30.55 (-1.67%)
GILD   75.02 (-0.32%)
DIS   115.35 (-1.53%)
NFLX   413.50 (+0.01%)
BA   144.10 (-3.82%)
AAPL   318.88 (+0.20%)
MSFT   181.97 (+0.31%)
FB   224.87 (-0.26%)
CGC   17.59 (-18.57%)
BABA   199.13 (-0.47%)
GE   6.54 (-3.68%)
TSLA   821.23 (+1.91%)
T   30.55 (-1.67%)
GILD   75.02 (-0.32%)
DIS   115.35 (-1.53%)
NFLX   413.50 (+0.01%)
BA   144.10 (-3.82%)
AAPL   318.88 (+0.20%)
MSFT   181.97 (+0.31%)
FB   224.87 (-0.26%)
CGC   17.59 (-18.57%)
BABA   199.13 (-0.47%)
GE   6.54 (-3.68%)
TSLA   821.23 (+1.91%)
T   30.55 (-1.67%)
GILD   75.02 (-0.32%)
DIS   115.35 (-1.53%)
NFLX   413.50 (+0.01%)
BA   144.10 (-3.82%)
AAPL   318.88 (+0.20%)
MSFT   181.97 (+0.31%)
FB   224.87 (-0.26%)
CGC   17.59 (-18.57%)
BABA   199.13 (-0.47%)
GE   6.54 (-3.68%)
TSLA   821.23 (+1.91%)
T   30.55 (-1.67%)
GILD   75.02 (-0.32%)
DIS   115.35 (-1.53%)
NFLX   413.50 (+0.01%)
BA   144.10 (-3.82%)
Log in

LON:VSNVerseon Share Price, Forecast & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average Volume560 shs
Market Capitalization£127.41 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Verseon Corporation, a pharmaceutical company, designs and develops novel therapeutics for various diseases in the United States. The company is involved in developing oral anticoagulants for various cardiovascular indications with novel pharmacology; kallikrein inhibitors for the treatment of diabetic macular edema and hereditary angioedema; and novel angiogenesis inhibitors for the treatment of solid tumors. Verseon Corporation was founded in 2002 and is headquartered in Fremont, California.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.48 out of 5 stars


Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-510-2259000

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book ValueGBX 21 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap£127.41 million
Next Earnings DateN/A
OptionableNot Optionable

Receive VSN News and Ratings via Email

Sign-up to receive the latest news and ratings for VSN and its competitors with MarketBeat's FREE daily newsletter.

Verseon (LON:VSN) Frequently Asked Questions

Has Verseon been receiving favorable news coverage?

News articles about VSN stock have trended positive on Friday, InfoTrie reports. The research group ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Verseon earned a coverage optimism score of 2.7 on InfoTrie's scale. They also gave media stories about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an effect on the company's share price in the immediate future. View the latest news aboutVerseon.

Who are some of Verseon's key competitors?

Who are Verseon's key executives?

Verseon's management team includes the following people:
  • Mr. Adityo Prakash, CEO & Exec. Director
  • Ms. Eniko Fodor, Founder, CFO, COO, Company Sec. & Exec. Director (Age 51)

What is Verseon's stock symbol?

Verseon trades on the London Stock Exchange (LON) under the ticker symbol "VSN."

How do I buy shares of Verseon?

Shares of VSN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How big of a company is Verseon?

Verseon has a market capitalization of £0.00.

What is Verseon's official website?

The official website for Verseon is www.verseon.com.

How can I contact Verseon?

Verseon's mailing address is 48820 Kato Rd Ste 100B, FREMONT, CA 94538-7323, United States. The company can be reached via phone at +1-510-2259000.

This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.